Deficits in Our Understanding of Natural Killer Cell Development in Mouse and Human

dc.contributor.authorSchorr, Christopher
dc.contributor.authorKrishnan, Maya Shraddha
dc.contributor.authorCapitano, Maegan
dc.contributor.departmentMicrobiology and Immunology, School of Medicine
dc.date.accessioned2024-09-16T07:44:08Z
dc.date.available2024-09-16T07:44:08Z
dc.date.issued2023
dc.description.abstractPurpose of review: Natural killer (NK) cells are a type of immune cell that play a crucial role in the defense against cancer and viral infections. The development and maturation of NK cells is a complex process, involving the coordination of various signaling pathways, transcription factors, and epigenetic modifications. In recent years, there has been a growing interest in studying the development of NK cells. In this review, we discuss the field's current understanding of the journey a hematopoietic stem cell takes to become a fully mature NK cell and detail the sequential steps and regulation of conventional NK leukopoiesis in both mice and humans. Recent findings: Recent studies have highlighted the significance of defining NK development stages. Several groups report differing schema to identify NK cell development and new findings demonstrate novel ways to classify NK cells. Further investigation of NK cell biology and development is needed, as multiomic analysis reveals a large diversity in NK cell development pathways. Summary: We provide an overview of current knowledge on the development of NK cells, including the various stages of differentiation, the regulation of development, and the maturation of NK cells in both mice and humans. A deeper understanding of NK cell development has the potential to provide insights into new therapeutic strategies for the treatment of diseases such as cancer and viral infections.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationSchorr C, Krishnan MS, Capitano M. Deficits in our understanding of natural killer cell development in mouse and human. Curr Opin Hematol. 2023;30(4):106-116. doi:10.1097/MOH.0000000000000765
dc.identifier.urihttps://hdl.handle.net/1805/43307
dc.language.isoen_US
dc.publisherWolters Kluwer
dc.relation.isversionof10.1097/MOH.0000000000000765
dc.relation.journalCurrent Opinion in Hematology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectNatural killer cells
dc.subjectDifferentiation
dc.subjectDevelopment
dc.subjectRegulation
dc.subjectAdoptive cellular therapy
dc.titleDeficits in Our Understanding of Natural Killer Cell Development in Mouse and Human
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Schorr2023Deficits-AAM.pdf
Size:
576.71 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: